Digital health's top deal-doers: These funds invested in the most companies last year

By Rock Health’s count, 302 investment firms and “notable angels” put money into a digital health startup in 2013. Twenty-seven of them did it three or more times.

That’s a big jump from the eight who did three or more deals in 2012. An influx of digital health exits, final guidance from the FDA on mobile apps, more good opportunities or any number of other factors may have led investors to pony up capital for more of these companies last year.

However, a few who topped this list last year, like Aberdare and NEA, laid low this year.

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

Here are the digital health investors who did the most deals in 2013:

The Social+Capital Partnership – 7 investments, including Asthmapolis, Breakthrough, NeuroTrack and Syapse
Norwest Venture Partners (NVP) – 6 investments, including Misfit Wearables, Basis Science and iRhythm
Cardinal Partners – 4 investments, including QPID and Vitals
Khosla Ventures – 4 deals, including HealthTap, Misfit Wearables and Jawbone
Merck Global Health Innovation Fund – 4 deals, including Medivo, Aviir and PatientSafe Solutions
Qualcomm Ventures – 4 investments, including Practice Fusion